drugset
drugset / Trial / NCT05529056

Study of Atropine Therapeutic Effect on Myopic Progression

NCT05529056 ↗

Phase 3 Unknown 472 enrolled LitePharmTech Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is to evaluate the therapeutic effect and safety of LPTAT in children with myopia.

Timeline

Start
2022-05-25
Primary completion
2023-06-30
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified — Other

Indications

myopia